Stock Movers: Schwab, Newsmax, Hims & Hers, and Trump Media Analysis

Charles Schwab Stock Performance

• 📈 Charles Schwab shares rose premarket following an upgrade from Citi to 'buy', with a price target of $102.
• 💡 Citi cited an improving outlook, strong first-quarter trading activity despite market volatility, and a less exposed core business.
• 🗣️ Schwab executives and Bloomberg Intelligence analyst Eric Balchunas noted that retail investors are stepping in to buy shares during selling pressure.

Newsmax IPO and Market Reaction

• 🚀 Newsmax (NMAX) shares are retreating after an initial surge of over 2,000% since its debut, experiencing significant volatility.
• 💰 Despite the stock's performance, the company is described as small with no profit, yet its market capitalization briefly surpassed Fox Corp.
• 👨‍💼 Founder and CEO Christopher Ruddy, owning one-third of the company, saw his net worth increase significantly, ranking him higher than other billionaires on the Bloomberg index.

Hims & Hers Health and Weight-Loss Drugs

• 💊 Hims & Hers Health (HIMS) shares initially rose on news of broadening its weight-loss offerings to include drugs like Eli Lilly's Zepbound.
• ⚠️ The stock turned down as Eli Lilly clarified it has no affiliation with Hims & Hers regarding Zepbound and that it can be prescribed by any licensed healthcare professional.
• 📺 The discussion touched upon the widespread advertising of weight-loss drugs like Ozempic and the availability of lower-cost versions.

Trump Media & Technology Group Stock Slump

• 📉 Trump Media & Technology Group (DJT) shares fell in pre-market trading due to a filing for the potential sale of up to 8.4 million shares by the company and 134.1 million by selling holders.
• 📢 The company issued a statement clarifying that the filing was a routine re-registration of already registered shares, not an indication of an immediate sale by affiliates.